Profile data is unavailable for this security.
About the company
SanBio Co Ltd is engaged in the regenerative cell business using allogeneic stem cells. The Company has the research and development base in the United States and conducts research, development, manufacture and sale of regenerative cell medicines in Japan. The Company aims to sell therapeutic agents for diseases with high unmet medical needs, mainly in diseases of the central nervous system. It is involved in the manufacture, development, non-clinical studies, clinical trials of technologies introduced from research institutes such as universities. The Company has five regenerative cell drugs, including the main product candidate SB623 (nerve regenerative cells), SB618 (function-enhancing type & Mesenchymal stem cells), SB308 (muscle stem cells), MSC1 (mesenchymal stem cells), and MSC2 (mesenchymal stem cells).
- Revenue in JPY (TTM)0.00
- Net income in JPY-2.16bn
- Incorporated2013
- Employees29.00
- LocationSanBio Co Ltd13F, St. Luke Tower, 8-1, Akashi-choCHUO-KU 104-0044JapanJPN
- Phone+81 362643481
- Websitehttps://www.sanbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nano Mrna Co Ltd | 76.60m | -650.31m | 14.55bn | 18.00 | -- | 4.45 | -- | 189.93 | -9.24 | -9.24 | 1.09 | 46.27 | 0.0145 | 24.08 | 1.45 | 4,255,556.00 | -12.33 | -24.16 | -13.57 | -25.17 | 78.30 | 84.69 | -848.97 | -600.70 | 9.24 | -- | 0.2540 | -- | -32.98 | -22.88 | 40.50 | -- | -- | -- |
| AnGes Inc | 449.34m | -6.11bn | 15.86bn | 145.00 | -- | 0.6149 | -- | 35.31 | -29.92 | -29.92 | 2.22 | 107.33 | 0.0139 | 0.1931 | 4.02 | 3,098,862.00 | -18.95 | -28.50 | -22.32 | -33.14 | 38.79 | 39.42 | -1,359.35 | -6,726.82 | 1.19 | -- | 0.013 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
| PRISM BioLab Co Ltd | -100.00bn | -100.00bn | 18.52bn | 22.00 | -- | 7.77 | -- | -- | -- | -- | -- | 66.29 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -79.63 | -- | -822.18 | -- | -- | -- |
| Healios KK | 522.00m | -5.39bn | 20.19bn | 64.00 | -- | 6.22 | -- | 38.68 | -68.16 | -68.16 | 6.56 | 36.00 | 0.0321 | -- | 1.61 | 8,156,250.00 | -33.11 | -23.55 | -49.17 | -28.52 | 85.06 | -- | -1,030.65 | -6,580.16 | -- | -1.49 | 0.7469 | -- | 34.44 | -- | 26.04 | -- | -22.00 | -- |
| Pharma Foods International Co., Ltd. | 63.21bn | 3.87bn | 27.39bn | 670.00 | 6.97 | 2.64 | 6.10 | 0.4334 | 135.20 | 135.20 | 2,207.45 | 356.76 | 1.75 | 2.10 | 12.31 | 94,343,280.00 | 10.69 | 8.40 | 35.14 | 19.20 | 79.54 | 81.34 | 6.12 | 3.85 | 0.8573 | 93.61 | 0.6565 | 28.26 | 13.94 | 53.90 | 923.80 | 57.92 | 51.63 | -- |
| Heartseed Inc | -100.00bn | -100.00bn | 36.41bn | 39.00 | -- | 7.92 | -- | -- | -- | -- | -- | 206.81 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 17.78 | -- | 0.0019 | -- | -30.93 | -- | -4.30 | -- | -- | -- |
| Shin Nippon Biomedical Laboratories Ltd | 26.20bn | 4.28bn | 50.29bn | 1.34k | 11.75 | 1.51 | 8.11 | 1.92 | 102.81 | 102.81 | 629.22 | 800.32 | 0.3631 | 1.08 | 5.74 | 19,533,940.00 | 5.89 | 10.54 | 8.47 | 15.93 | 53.88 | 52.73 | 16.23 | 25.32 | 0.8013 | -- | 0.5014 | 25.88 | 5.42 | 11.05 | -8.73 | 23.18 | 50.90 | 75.54 |
| Chordia Therapeutics Inc | -100.00bn | -100.00bn | 52.63bn | 21.00 | -- | 13.25 | -- | -- | -- | -- | -- | 58.88 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 112.55 | -- | -- | -- |
| SanBio Co Ltd | 0.00 | -2.16bn | 71.79bn | 29.00 | -- | 29.92 | -- | -- | -32.93 | -32.93 | 0.00 | 34.97 | 0.00 | -- | -- | 0.00 | -41.79 | -42.00 | -48.20 | -48.88 | -- | -- | -- | -4,790.72 | -- | -- | 0.1995 | -- | -- | -- | 52.44 | -- | 53.94 | -- |
| GNI Group Ltd | 23.65bn | 6.77bn | 114.62bn | 843.00 | 17.51 | 3.11 | 18.58 | 4.85 | 130.73 | 130.73 | 467.09 | 735.86 | 0.4147 | 1.89 | 3.72 | 28,052,010.00 | 9.50 | 7.23 | 11.52 | 8.80 | 81.38 | 85.75 | 22.90 | 14.57 | 2.55 | 8.79 | 0.1321 | 0.00 | 49.32 | 38.97 | 1,981.71 | -- | 19.69 | -- |
| Takara Bio Inc | 42.82bn | 114.00m | 125.35bn | 1.84k | 1,099.53 | 1.13 | 25.26 | 2.93 | 0.9468 | 0.9468 | 355.62 | 923.50 | 0.3533 | 1.49 | 5.13 | 23,298,150.00 | 0.1196 | 10.06 | 0.1296 | 11.38 | 57.84 | 64.39 | 0.3386 | 18.84 | 6.16 | -- | 0.00 | 27.54 | -44.33 | 3.95 | -90.76 | -16.55 | 16.18 | 19.42 |
| Peptidream Inc | 55.42bn | 21.69bn | 332.83bn | 603.00 | 15.32 | 5.65 | 13.84 | 6.01 | 167.15 | 167.15 | 427.44 | 453.44 | 0.7217 | 4.49 | 2.97 | 91,906,740.00 | 28.25 | -- | 33.81 | -- | 77.98 | -- | 39.14 | -- | 3.23 | 14.72 | 0.2626 | -- | 6.93 | -- | -59.81 | -- | -- | -- |
Data as of Aug 30 2024. Currency figures normalised to SanBio Co Ltd's reporting currency: Japanese Yen JPY
2.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.19m | 1.73% |
| Simplex Asset Management Co., Ltd.as of 08 Aug 2024 | 266.50k | 0.39% |
| SSgA Funds Management, Inc.as of 08 Aug 2024 | 202.50k | 0.30% |
| BlackRock Investment Management (UK) Ltd.as of 31 Dec 2023 | 10.50k | 0.02% |
| Mercer Global Investments Europe Ltd.as of 30 Jun 2023 | 7.40k | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd.as of 31 Dec 2023 | 6.40k | 0.01% |
| Bank J. Safra Sarasin AG (Investment Management)as of 30 Sep 2023 | 4.50k | 0.01% |
| Global X Japan Co., Ltd.as of 08 Aug 2024 | 3.90k | 0.01% |
| Pictet Asset Management SAas of 31 Mar 2024 | 1.80k | 0.00% |
| Irish Life Investment Managers Ltd.as of 31 Dec 2023 | 1.10k | 0.00% |
More ▼
Data from 28 Jun 2024 - 29 Aug 2024Source: FactSet Research Systems Inc.
